• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [22857 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     HAYES, Inc. Ultrasound guidance to aid in the placement of peripherally inserted central catheter lines
2007     Adelaide Health Technology Assessment (AHTA) Ultrasound for assessment of risk of fracture
2000     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Ultrasound diagnostic during pregnancy
2003     Institute for Clinical Systems Improvement (ICSI) Ultrasound cervical length for the prediction of preterm labor
2015     HAYES, Inc. Ultrasound bone growth stimulation
2003     HAYES, Inc. Ultrasound bone growth stimulation
2009     HAYES, Inc. Ultrasound bone growth stimulation
2000     ECRI Ultrasound bone densitometry for diagnosis of osteoporosis
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment
2002     Blue Cross Blue Shield Association (BCBS) Ultrasonography of peripheral sites for selecting patients for pharmacologic treatment for osteoporosis
1998     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Ultrasonography in primary health care. IPE-98/16 (Public report)
2014     Malaysian Health Technology Assessment (MaHTAS) Ultrasonic wound debridement device
2014     Agenzia nazionale per i servizi sanitari regionali (Agenas) Ultrasonic energy devices for surgery
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ultrasonic cutting and coagulating devices
2015     Health Quality Ontario (HQO) Ultrafiltration in heart failure: a rapid review
2013     HAYES, Inc. Ultrafiltration in congestive heart failure
2008     VA Technology Assessment Program (VATAP) Ultrafiltration for heart failure
2010     VA Technology Assessment Program (VATAP) Ultrafiltration for decompensated heart failure
2006     NIHR Horizon Scanning Centre (NIHR HSC) Ultrafiltration for acute decompensated heart failure: horizon scanning technology briefing
2007     HAYES, Inc. Ultrafiltration for acute decompensated congestive heart failure
2003     Adelaide Health Technology Assessment (AHTA) Ultrafast magnetic resonance imaging (MRI) for patients undergoing conventional MRI
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ultra-low-dose Danazol (Optina; Vasaloc) for diabetic macular oedema
2023     Health Information and Quality Authority (HIQA) Ultra-hypofractionated adjuvant radiotherapy for breast cancer: evidence synthesis to support a generic justification decision
2015     Adelaide Health Technology Assessment (AHTA) Ultra-filtration for patients with decompensated heart failure
2022     NIHR Health Technology Assessment programme Ulipristal acetate versus conventional management of heavy menstrual bleeding (HMB; including uterine fibroids): a randomised controlled trial and exploration of mechanism of action (UCON trial)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ulipristal Acetate (Fibristal - Actavis Specialty Pharmaceuticals Co.) indication: uterine fibroids
2016     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ularitide for acute decompensated heart failure – first line
2020     NIHR Health Services and Delivery Research programme UK Study of tendon Achilles Rehabilitation multicentre randomised clinical trial (UK STAR)
2018     NIHR Health Technology Assessment programme UK Lung Cancer Screening Trial (UKLS) - Feasibility study and protocol development
1995     NIHR Health Technology Assessment programme UK home parenteral nutrition register
2016     NIHR Health Technology Assessment programme UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2016     NIHR Health Technology Assessment programme UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2015     NIHR Health Technology Assessment programme UK DRAFFT: a randomised controlled trial of percutaneous fixation with Kirschner wires versus volar locking-plate fixation in the treatment of adult patients with a dorsally displaced fracture of the distal radius
2021     NIHR Health Technology Assessment programme UK Cohort study to Investigate the prevention of Parastomal Hernia (CIPHER)
2010     HAYES, Inc. UGT1A1 Sequence Variant Testing for Predicting Response to Irinotecan Therapy in Colorectal Cancer
2022     National Institute for Health and Care Excellence (NICE) TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal). NICE technology appraisal guidance 790
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors, immune checkpoint inhibitors and everolimus for treating advanced renal cell cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating MET mutation-positive metastatic non-small-cell lung cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating ALK mutation-positive advanced non-small-cell lung cancer
2014     Malaysian Health Technology Assessment (MaHTAS) Typhoid carrier test (Typhidot-C)
2012     NIHR Health Technology Assessment programme Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antisepticimpregnated urethral catheters (the CATHETER trial)
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Type 2 diabetes. Health technology assessment of screening, diagnosis and treatment
2004     National Institute for Clinical Excellence (NICE) Type 2 diabetes: Prevention and management of foot problems
2004     National Institute for Clinical Excellence (NICE) Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults
2017     Agency for Healthcare Research and Quality (AHRQ) Tympanostomy tubes in children with otitis media
2002     HAYES, Inc. Tympanoplasty for recurrent and chronic otitis media
2006     University HealthSystem Consortium (UHC) Tygacil
2022     Medical Services Advisory Committee (MSAC) Two testing options for determining eligibility for access to Pharmaceutical Benefits Schedule-subsidised aducanumab in patients with early stage Alzheimer disease
2020     NIHR Health Technology Assessment programme Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT
2018     NIHR Health Technology Assessment programme Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study
2012     Medical Advisory Secretariat (MAS) Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis
2014     Health Quality Ontario (HQO) Turning for ulcer reduction (TURN) study: an economic analysis
2014     Health Quality Ontario (HQO) Turning for the prevention and management of pressure ulcers: OHTAC Recommendation
2022     National Institute for Health and Care Excellence (NICE) Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis. NICE interventional procedures guidance 746
2011     Penn Medicine Center for Evidence-based Practice (CEP) Tunneled vs. non-tunneled catheters for acute hemodialysis
2003     The Swedish Council on Health Technology Assessment (SBU) TUNA - Transurethral needle ablation for BPH - early assessment briefs (Alert)
2023     Scottish Health Technologies Group (SHTG) Tumour profiling tests to guide chemotherapy decisions in early breast cancer
2019     NIHR Health Technology Assessment programme Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2016     NIHR Health Technology Assessment programme Tumour necrosis factor- inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation
2002     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Medical efficacy
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Economic efficiency
2003     The Swedish Council on Health Technology Assessment (SBU) Tumor vaccination- early assessment briefs (Alert)
2024     Swiss Federal Office of Public Health (FOPH) Tumor treating fields (TTFields) therapy for patients with glioblastoma multiforme
2011     HAYES, Inc. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS; Familial Hibernian Fever)
2002     Health Technology Advisory Committee (HTAC) Tumescent liposuction
2001     HAYES, Inc. Tumescent liposuction
2022     National Institute for Health and Care Excellence (NICE) Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies. NICE technology appraisal guidance 786
2010     HAYES, Inc. Tuberous Sclerosis Complex (TSC; Bourneville Disease)
2006     National Institute for Health and Care Excellence (NICE) Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) TruScan
2008     NIHR Horizon Scanning Centre (NIHR HSC) TroVax (MVA-5T4) for locally advanced or metastatic renal cell carcinoma – with first line therapy
1997     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Troglitazone for Type II diabetes
2011     HAYES, Inc. Trofile™ HIV tropism assay
2016     NIHR Horizon Scanning Centre (NIHR HSC) Triptorelin (Decapeptyl SR) for premenopausal women with early endocrine responsive breast cancer
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for migraine headaches: a review of clinical evidence on safety
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for acute migraine: comparative clinical effectiveness and cost-effectiveness
2000     British Columbia Office of Health Technology Assessment (BCOHTA) Triple-marker screening in British Columbia: current practice, future options
2019     Penn Medicine Center for Evidence-based Practice (CEP) Triple-lumen peripherally-inserted central catheters
2018     NIHR Health Technology Assessment programme Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for moderate-to-severe chronic obstructive pulmonary disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for hepatitis C in previous non-responders: a review of the clinical effectiveness and safety
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Triple therapy for COPD
2021     Austrian Institute for Health Technology Assessment (AIHTA) Triphasic biomaterial for augmentation of the osteoporotic femoral neck: systematic review
2021     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Triphasic biomaterial for augmentation of the osteoporotic femoral neck
2022     Swiss Federal Office of Public Health (FOPH) Trimonthly vs. monthly use of bone-targeted agents in patients with bone metastases and multiple myeloma
2010     Adelaide Health Technology Assessment (AHTA) Triggerfish continuous intraocular pressure monitoring system for the improved management of glaucoma patients
2002     Alberta Heritage Foundation for Medical Research (AHFMR) Trigger point injections for non-malignant chronic pain
2009     HAYES, Inc. Trigger point injections for myofascial pain
2013     HAYES, Inc. Trigger point injections for myofascial pain
2005     Alberta Heritage Foundation for Medical Research (AHFMR) Trigger point injections for chronic non-malignant musculoskeletal pain
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Trigeminal nerve stimulation to treat neuralgia
2022     National Institute for Health and Care Excellence (NICE) Trifluridinetipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatments. NICE technology appraisal guidance 852
2016     National Institute for Health and Care Excellence (NICE) Trifluridine-tipiracil for previously treated metastatic colorectal cancer. NICE technology appraisal guidance 405
2016     HAYES, Inc. Trifluridine-tipiracil (Lonsurf) for refractory metastatic colorectal cancer
2009     HAYES, Inc. TriFlange acetabular prosthesis for failed total hip arthroplasty with massive acetabular defects
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Trientine for treatment of Wilson's disease: clinical and cost-effectiveness, and safety